Page last updated: 2024-10-24

positive regulation of cell cycle G1/S phase transition

Definition

Target type: biologicalprocess

Any signaling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle. [GO_REF:0000058, GOC:mtg_cell_cycle, GOC:TermGenie]

The G1/S phase transition is a crucial checkpoint in the cell cycle, ensuring that cells only progress into DNA replication and division when appropriate conditions are met. This process is tightly regulated by a complex network of proteins and signaling pathways, and its positive regulation involves the coordinated activation of key molecular players that promote entry into S phase.

**Cyclin D and CDK4/6 activation:** The first step in positive regulation of G1/S transition involves the accumulation of cyclin D proteins. These cyclins bind to cyclin-dependent kinases 4 and 6 (CDK4/6), activating their catalytic activity. CDK4/6 phosphorylate the retinoblastoma protein (Rb), which is a key inhibitor of cell cycle progression.

**Rb phosphorylation and E2F release:** As CDK4/6 activity increases, Rb becomes progressively phosphorylated. This phosphorylation disrupts Rb's ability to bind to and inhibit transcription factors known as E2F proteins. E2F proteins are essential for the transcription of genes required for DNA replication and cell cycle progression.

**E2F activation and gene expression:** Upon release from Rb, E2F proteins become active and stimulate the expression of genes encoding components of the DNA replication machinery, including DNA polymerases, helicases, and other proteins necessary for S phase entry.

**Cyclin E and CDK2 activation:** The expression of E2F target genes also includes genes encoding cyclin E. Cyclin E binds to CDK2, activating its kinase activity. CDK2 further phosphorylates Rb and other substrates, reinforcing the signal for S phase entry.

**Other positive regulators:** In addition to the core CDK/cyclin pathway, other proteins and signaling cascades contribute to the positive regulation of G1/S transition. These include:
* **Growth factor signaling pathways:** Growth factors like epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) stimulate cell proliferation by activating downstream signaling pathways that promote cyclin D expression and CDK4/6 activity.
* **Myc oncogene:** Myc is a transcription factor that can enhance cyclin D and E expression, promoting G1/S progression.
* **PI3K/Akt pathway:** This pathway is activated by growth factors and other stimuli and can lead to the activation of CDK4/6 and the inhibition of G1-phase inhibitors like p27.

**Overall, the positive regulation of G1/S phase transition is a tightly controlled process that integrates multiple signaling pathways and molecular interactions. This intricate regulation ensures that cells only enter DNA replication and division when appropriate conditions are met, thereby preventing uncontrolled proliferation and maintaining genomic stability.**'
"

Proteins (2)

ProteinDefinitionTaxonomy
Histone-lysine N-methyltransferase EZH2A histone-lysine N-methyltransferase EZH2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15910]Homo sapiens (human)
Zinc finger protein GLI1A zinc finger protein GLI1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08151]Homo sapiens (human)

Compounds (18)

CompoundDefinitionClassesRoles
staurosporine aglyconestaurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
betulinic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
3-deazaneplanocin3-deazaneplanocin: S-adenosylhomocysteine hydrolase antagonist
tanshinonetanshinone: from root of Salvia miltiorrhiza Bunge; RN given refers to tanshinone I; cardioprotective agent and neuroprotective agentabietane diterpenoidanticoronaviral agent
przewaquinone dprzewaquinone D: isolated from root of Salvia przewalskii; structure given in first source; RN given refers to the trans- isomer, przewaquinone D
ceanothic acidceanothic acid: isolated from Ceanothus americanus; structure in first source
tanshinone ii atashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first sourceabietane diterpenoid
gant 61GANT 61: a sonic hedgehog pathway inhibitor and Gli inhibitor; structure in first source

GANT61 : An aminal that is hexahydropyrimidine which is substituted on each nitrogen by a 2-(dimethylamino)benzyl group, and at the aminal carbon by a pyridin-4-yl group. A Hedgehog signaling pathway and Gli protein inhibitor.
aminal;
dialkylarylamine;
pyridines;
substituted aniline;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
glioma-associated oncogene inhibitor;
Hedgehog signaling pathway inhibitor
s-adenosylhomocysteineS-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine.

S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide
cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
zerumbonezerumbone : A sesquiterpenoid and cyclic ketone that is (1E,4E,8E)-alpha-humulene which is substituted by an oxo group at the carbon atom attached to two double bonds. It is obtained by steam distillation from a type of edible ginger, Zingiber zerumbet Smith, grown particularly in southeast Asia.

zerumbone: RN given for (E,E,E)-isomer; structure in first source
cyclic ketone;
sesquiterpenoid
anti-inflammatory agent;
glioma-associated oncogene inhibitor;
plant metabolite
nsc-287088
2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acid2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acid : A pentacyclic triterpenoid that is betulinic acid carrying an additional alpha-hydroxy group at position 2. It has been isolated from Breynia fruticosa.

alphitolic acid: from the aerial parts of Gouania longipetala; structure in first source
dihydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite
physalin fphysalin F : A physalin with antimalarial and antitumour activities isolated from Physalis angulata.

physalin F: has immunosuppressive activity; from Physalis angulata L; structure given in first source
enone;
epoxy steroid;
lactone;
physalin
antileishmanial agent;
antimalarial;
antineoplastic agent;
apoptosis inducer;
immunosuppressive agent
epz005687EPZ005687: inhibits EZH2 protein; structure in first sourceindazoles
epz-6438tazemetostat: a histone methyltransferase EZH2 inhibitor with antineoplastic activity
gsk-2816126GSK-2816126: inhibits EZH2 methyltransferase; structure in first sourcepiperazines;
pyridines
gsk343GSK343 : A member of the class of indazoles that is 1-isopropyl-1H-indazole-4-carboxamide in which the nitrogen of the carboxamide group is substituted by a (6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl group and in which the indazole ring is substituted at position 6 by a 2-(4-methylpiperazin-1-yl)pyridin-4-yl group. A highly potent and selective EZH2 inhibitor (IC50 = 4 nM).

GSK343: an EZH2 methyltransferase inhibitor
aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide(R)-1-(1-(1-(ethylsulfonyl)piperidin-4-yl)ethyl)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1H-indole-3-carboxamide: EZH2 inhibitorindolecarboxamide